6 completed, 1 active not recruiting, 1 unknown. 8 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 6, Active not recruiting 1, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
Follow Atropine Sulfate: new trials by email Literature Review of Atropine Sulfate trials Research Report on Atropine Sulfate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation. Dexmedetomidine infusion, Dexmedetomidine bolus, Atropine Sulfate - Dexmedetomidine, Intubation Complication | Phase 2 | Completed | Kasr El Aini Hospital | 70 | 2024-04-01 | 2026-07-09 |
| Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop CBT-009, Vehicle, Atropine Sulfate - Myopia, Progressive | Phase 1 / Phase 2 | Completed | Cloudbreak Therapeutics, LLC | 84 | 2022-07-20 | 2023-01-27 |
| Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom Atropine Sulfate, Placebo - Myopia | Phase 2 | Active not recruiting | Belfast Health and Social Care Trust | 289 | 2019-04-03 | 2023-09-07 |
| Side Effects of Atropine (SEA) Study 0.01% concentration atropine drops - Myopia | Phase 1 / Phase 2 | Completed | Jeffrey J. Walline, OD PhD | 31 | 2018-07-23 | 2022-12-02 |
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 224 | 2017-01-27 | 2026-03-09 |
| The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC) Lidocaine, Sevoflurane, TIVA-TCI - Breast Cancer | Phase 2 | Completed | Iuliu Hatieganu University of Medicine and Pharmacy | 120 | 2016-08-01 | 2019-10-29 |
| StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study PSE 120 mg, CM 8 mg, Atr 0.36 mg, PSE 120 mg, CM 8 mg, Atr 0.24 mg, PSE 120 mg, CM 8 mg, Atr 0.12 mg - Rhinitis, Seasonal, Allergic | Phase 2 | Unknown | Magna Pharmaceuticals, Inc. | 125 | 2014-03-01 | 2014-05-30 |
| Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome Epinephrine, Intravenous needle, Atropine - Cardiac Arrest | Phase 2 | Completed | Petter Andreas Steen | 904 | 2003-01-01 | 2015-05-29 |
Myopia (2) · Breast Neoplasms (1) · Carcinoma in Situ (1) · Heart Arrest (1) · Myopia, Degenerative (1) · Papillomavirus Infections (1) · Photophobia (1) · Rhinitis (1) · Rhinitis, Allergic, Seasonal (1) · Uterine Cervical Dysplasia (1) · Vulvar Diseases (1) · Vulvar Neoplasms (1)
Belfast Health and Social Care Trust (1) · Cloudbreak Therapeutics, LLC (1) · Iuliu Hatieganu University of Medicine and Pharmacy (1) · Jeffrey J. Walline, OD PhD (1) · Kasr El Aini Hospital (1) · Magna Pharmaceuticals, Inc. (1) · National Cancer Institute (NCI) (1) · Petter Andreas Steen (1)
United States (3) · Australia (1) · Egypt (1) · Norway (1) · Romania (1) · United Kingdom (1)
Augusto Azuara-Blanco, PhD FRCOphth (1) · Jeffrey Walline (1) · Lars Wik, MD, PhD (1) · Scott M Norberg, D.O. (1) · Stephen J Pollard, MD (1) · Tanya Revell, MD (1)
PMID 19934423, PMID 24247230, PMID 25794212, PMID 31653669, PMID 32616309, PMID 33558725, PMID 42276557
2017 (1)